Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy (Q35131218)

6 August 2017

1 reference

title

Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy (English)

1 reference

Herpes simplex virus type 1

6 August 2017

0 references

1 reference

Bowers WJ

1

1 reference

6 August 2017

Olschowka JA

series ordinal

2

1 reference

6 August 2017

Federoff HJ

series ordinal

3

1 reference

6 August 2017

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

10

1 reference

6 August 2017

11

1 reference

6 August 2017

941-945

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302047

6 August 2017

0 references

cites work

A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Infections with herpes simplex viruses (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Masters of deception: a review of herpesvirus immune evasion strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Herpesviruses--Immune Escape Artists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Vaccines against genital herpes: progress and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Immunological hiding of herpesvirus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Characterization of RNA transcripts from herpes simplex virus-1 DNA fragment BamHI-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Gene transfer into mammalian central nervous system using herpes virus vectors: extended expression of bacterial lacZ in neurons using the neuron-specific enolase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene Transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Gene transfer to brain using herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Herpesvirus vector gene transfer and expression of beta-glucuronidase in the central nervous system of MPS VII mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Replication-defective herpes simplex virus vectors for gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

HSV-1 amplicon vectors--simplicity and versatility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Design and application of HSV vectors for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

Transfer of human HPRT gene sequences into neuronal cells by a herpes simplex virus derived vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

In vitro neutralization of HSV-2: Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

An infectious transfer and expression system for genomic DNA loci in human and mouse cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

An enhanced packaging system for helper-dependent herpes simplex virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302047

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302047

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference